Sumitomo Pharma shares received an improved outlook from Jefferies as analyst Stephen Barker upgraded the company's stock rating from Hold to Buy, accompanied by a price target increase to JPY900 from ...

Novo Nordisk subsequently developed Wegovy to specifically target weight-loss ... more than tripled in value as Mounjaro sales took off, the pharmaceutical distributors are the better GLP-1 ...

Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 ...

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Ironwood Pharma (IRWD – Research Report), with a price ...

On Friday, when AbbVie reported its quarterly earnings, the pharma giant jacked up its 2027 projected sales of Humira follow-ons Skyrizi and Rinvoq to a combined $31 billion. It is a $4 billion ...

The firm noted Verona Pharma's impressive Q4 sales figures for Ohtuvayre™, which reached $36 million, a 6.4-fold increase over Q3 of the same year. Truist Securities increased the price target for ...

Sun Pharma’s strong Q3 performance topped expectations, but concerns over Leqselvi’s delayed launch and reduced R&D spending have prompted caution amid brokerages.